These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17490723)

  • 1. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
    Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
    Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
    Coleman LW; Bronstein IB; Holden JA
    Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R; Alanen K; Syrjänen S
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.
    Berney DM; Stankiewicz E; Adlan AM; Kudahetti S; Biedrzycki OJ; Hadway P; Watkin N; Corbishley C
    BJU Int; 2008 Sep; 102(8):1040-4. PubMed ID: 18489530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D; Babić D; Forko JI; Martinac I
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
    Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
    Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma.
    Yoshida Y; Kurokawa T; Fukuno N; Nishikawa Y; Kamitani N; Kotsuji F
    Hum Pathol; 2000 Dec; 31(12):1448-54. PubMed ID: 11150369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.
    Hafian H; Venteo L; Sukhanova A; Nabiev I; Lefevre B; Pluot M
    Hum Pathol; 2004 Jun; 35(6):745-51. PubMed ID: 15188142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
    Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
    Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
    Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
    Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
    Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
    J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
    Sun X; Mittal K
    Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma.
    Watanuki A; Ohwada S; Fukusato T; Makita F; Yamada T; Kikuchi A; Morishita Y
    Anticancer Res; 2002; 22(2B):1113-9. PubMed ID: 12168909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
    Aoyagi S; Akiyama M; Shimizu H
    J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis.
    Cohen T; Prus D; Shia J; Abu-Wasel B; Pinto MG; Freund HR; Stojadinovic A; Grakov A; Peretz T; Nissan A
    J Surg Oncol; 2008 Apr; 97(5):416-22. PubMed ID: 18286523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative activity, p53 accumulation and neoangiogenesis in pulmonary carcinosarcomas and pulmonary blastomas.
    Theegarten D; Zorn M; Philippou S
    Gen Diagn Pathol; 1998 Apr; 143(5-6):265-70. PubMed ID: 9653906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.